256 related articles for article (PubMed ID: 30658262)
1. A cross-sectional study on the relationship between cardiorespiratory fitness, disease severity and walking speed in persons with Multiple Sclerosis.
Madsen LT; Dalgas U; Hvid LG; Bansi J
Mult Scler Relat Disord; 2019 Apr; 29():35-40. PubMed ID: 30658262
[TBL] [Abstract][Full Text] [Related]
2. Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
Feys P; Bibby BM; Baert I; Dalgas U
Eur J Phys Rehabil Med; 2015 Apr; 51(2):207-10. PubMed ID: 25180640
[TBL] [Abstract][Full Text] [Related]
3. Body composition and disability in people with multiple sclerosis: A dual-energy x-ray absorptiometry study.
Pilutti LA; Motl RW
Mult Scler Relat Disord; 2019 Apr; 29():41-47. PubMed ID: 30658263
[TBL] [Abstract][Full Text] [Related]
4. Walking capacities in multiple sclerosis measured by global positioning system odometer.
Créange A; Serre I; Levasseur M; Audry D; Nineb A; Boërio D; Moreau T; Maison P;
Mult Scler; 2007 Mar; 13(2):220-3. PubMed ID: 17439888
[TBL] [Abstract][Full Text] [Related]
5. [Information processing speed and influential factors in multiple sclerosis].
Zhang ML; Xu EH; Dong HQ; Zhang JW
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Thouvenot E; Orsini M; Daures JP; Camu W
Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
[TBL] [Abstract][Full Text] [Related]
8. Responder rates to fampridine differ between clinical subgroups of MS patients and patient reported outcome influences treatment decision making.
van Munster CEP; Kaya L; Lam KH; Kalkers NF; Killestein J; Uitdehaag BMJ
Mult Scler Relat Disord; 2020 Feb; 38():101489. PubMed ID: 31731213
[TBL] [Abstract][Full Text] [Related]
9. Performed and perceived walking ability in relation to the Expanded Disability Status Scale in persons with multiple sclerosis.
Langeskov-Christensen D; Feys P; Baert I; Riemenschneider M; Stenager E; Dalgas U
J Neurol Sci; 2017 Nov; 382():131-136. PubMed ID: 29111007
[TBL] [Abstract][Full Text] [Related]
10. The Influence of Cognitive Impairment on the Fitness-Cognition Relationship in Multiple Sclerosis.
Sandroff BM; Motl RW; Deluca J
Med Sci Sports Exerc; 2017 Jun; 49(6):1184-1189. PubMed ID: 28121803
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Walking-Related Motor Fatigue in Persons With Multiple Sclerosis: Decline in Walking Distance Induced by the 6-Minute Walk Test.
Leone C; Severijns D; Doležalová V; Baert I; Dalgas U; Romberg A; Bethoux F; Gebara B; Santoyo Medina C; Maamâgi H; Rasova K; Maertens de Noordhout B; Knuts K; Skjerbaek A; Jensen E; Wagner JM; Feys P
Neurorehabil Neural Repair; 2016 May; 30(4):373-83. PubMed ID: 26216790
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary fitness is related to disease severity in multiple sclerosis.
Heine M; Wens I; Langeskov-Christensen M; Verschuren O; Eijnde BO; Kwakkel G; Dalgas U
Mult Scler; 2016 Feb; 22(2):231-8. PubMed ID: 26014607
[TBL] [Abstract][Full Text] [Related]
13. Does disability level impact the relationship of muscle strength to walking performance in people with multiple sclerosis? a cross-sectional analysis.
Mañago MM; Callesen J; Dalgas U; Kittelson J; Schenkman M
Mult Scler Relat Disord; 2020 Jul; 42():102052. PubMed ID: 32240963
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of the actibelt(®) accelerometer for measuring walking speed in a controlled environment among persons with multiple sclerosis.
Motl RW; Weikert M; Suh Y; Sosnoff JJ; Pula J; Soaz C; Schimpl M; Lederer C; Daumer M
Gait Posture; 2012 Feb; 35(2):192-6. PubMed ID: 21945386
[TBL] [Abstract][Full Text] [Related]
15. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
[TBL] [Abstract][Full Text] [Related]
16. Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
Costa SL; DeLuca J; Sandroff BM; Goverover Y; Chiaravalloti ND
J Int Neuropsychol Soc; 2018 Feb; 24(2):139-146. PubMed ID: 28830576
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and motor function in people with multiple sclerosis in Stockholm County.
Einarsson U; Gottberg K; von Koch L; Fredrikson S; Ytterberg C; Jin YP; Andersson M; Holmqvist LW
Mult Scler; 2006 Jun; 12(3):340-53. PubMed ID: 16764349
[TBL] [Abstract][Full Text] [Related]
18. Natural history of secondary-progressive multiple sclerosis.
Tremlett H; Yinshan Zhao ; Devonshire V
Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
[TBL] [Abstract][Full Text] [Related]
19. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
Gava G; Bartolomei I; Costantino A; Berra M; Venturoli S; Salvi F; Meriggiola MC
Fertil Steril; 2014 Jul; 102(1):116-22. PubMed ID: 24794311
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
Planche V; Gibelin M; Cregut D; Pereira B; Clavelou P
Eur J Neurol; 2016 Feb; 23(2):282-9. PubMed ID: 25903918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
